Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis PAGE 31 (2023) Abstr 10456 Barceló C, Tanneau L, Acharya C, Ribbing J, Zecchin C, Schalkwijk S. ConferenceInflammationPharmacometricsSpecial considerations Pharmetheus Affiliates Director, MIDD Consultant Catalina Barceló See bio Director, MIDD Consultant Lénaïg Tanneau See bio Senior Director, MIDD Consultant Chayan Acharya See bio Principal Director, MIDD Consultant & Senior Expert Jakob Ribbing See bio
